Japanese consumer healthcare company, Rohto Mentholatum Group, has launched operations in Kenya after signing a Sh100 million investment deal.
The giant pharmaceutical company launched Rohto Mentholatum Kenya and unveiled a new range of products named Rootia. The firm will use the entry into the Kenyan market as a launching pad into the larger East African region.